M&A Awards Belgium: Panel of Judges nominates 15 deals – Bluebee/Illumina transaction is nominated

News
- 10/11/2020

The M&A Awards 2020 will be presented on Thursday 18 March 2021 (if the health statusand covid-19 measures allow for it) at the magnificent Hôtel de la Poste in Brussels. For thethird year in a row, the top in M&A, corporate finance and private equity will gather at ablack-tie gala dinner. Our panel of judges, consisting of captains of industry and experts inM&A, has nominated fifteen deals in five categories. The winners will be announced duringthe award show on 18 March 2021.

Nominees Best Venture Capital – Life Sciences Deal 2020
  • ExeVir Bio
  • Illumina acquires BlueBee
  • iTeos Therapeutics

The panel of judges nominates ExeVir Bio, whose technology is not only promising forcovid-19, but also for other viral diseases. The start-up gets support from UCB and is led bya very competent management team.

Secondly, the acquisition of BlueBee by Illumina is nominated because of the nicecomplementarity. BlueBee’s technology of “DNA sequencing” is a strategic quantum leap formedicine.

Finally, iTeos Therapeutics deserves a nomination for the biggest funding round of the year. In the heat of the corona crisis, the company that develops immuno-oncology therapy, succeeded to raise an enormous amount amongst both existing and new investors and shortly after was listed at Nasdaq.

More info on the M&A Awards website.